Lasix® ONYU was approved by the FDA on January 15, 2023 for the treatment of congestion due to fluid overload in adult patients with New York Heart Association (NYHA) Class II – IV chronic heart failure.  
Visit www.lasix-onyu.com for details and important safety information.

Introducing Lasix® ONYU

A wearable device providing hospital IV-strength diuresis for at-home use.

Thoughtful development

Designing the Lasix® ONYU Infusor with patients, providers, payors, and the environment in mind.

A New Era with a Legendary Name

Our team at SQ Innovation has developed a novel drug formulation and a subcutaneous Infusor to provide hospital IV-strength diuresis for at-home use. A small volume of a novel formulation of Lasix has been developed to be administered by our mini patch pump Infusor.

The Infusor uses the diuretic furosemide which was introduced in 1964 under the trademark Lasix.   The name Lasix ONYU builds on the trusted reputation of this famous trademark.   

The Infusor was specifically designed for use with our novel furosemide formulation in patients with heart failure. The thoughtful design considered the needs of patients, providers, patients and the environment.

Subcutaneous drug delivery is not new (it was first developed in 1853.   Now we have made it convenient, comfortable, affordable, and ready for widespread distribution.

Lasix ONYU was approved by the FDA on January 15, 2023 for the treatment of congestion due to fluid overload in adult patients with New York Heart Association (NYHA) Class II – IV chronic heart failure. 

Visit www.lasix-onyu.com for details and important safety information.

Lasix SQF Infusor Decongestion 2.0 At Home Candidate
Lasix SQF Infusor At Home Patients Discussing

Our Focus

Our focus is to bring products to the market that improve the quality of patient care and reduce the cost of care.

Our Product 

Our first product is the Lasix® ONYU Infusor, a wearable device providing hospital IV-strength diuresis for at-home use for heart failure patients.

Careers

Interested in joining the SQ Innovation team? We’re looking for talented, motivvated team members tto join our growing team.

Newsroom

PRESS RELEASE

Jan 15, 2024

Lasix® ONYU from SQ Innovation is first-time approved by the FDA

IN THE NEWS

Jan 15, 2024

SQ Innovation & EVERSANA Launch Lasix ONYU following FDA Approval

IN THE NEWS

Nov 27, 2023

Glasgow heart failure breakthrough welcomed by patients

The-Herald-logo

Stay Updated

 

Sign up for our email list below to receive periodic updates from SQ Innovation, Inc. on the Lasix SQF Infusion as we continue development and go to market.

Thank you! You have successfully subscribed!

Stay Updated

Sign up for our email list below to receive periodic updates from SQ Innovation, Inc. on the Lasix SQF Infusion as we continue development and go to market.

You have Successfully Subscribed!